Clinical information and resources are available in multiple languages.
- Deutsch (German)
- Español (Spanish)
- Français (French)
- Italiano (Italian)
- Português (Portuguese)
Medtronic Neuromodulation has entered in an agreement with the U.S. Food and Drug Administration (FDA) related to the SynchroMed drug infusion system and the Neuromodulation quality system.
Provided on this website relating to the agreement are: